Targeting GPCRs Against Cardiotoxicity Induced by Anticancer Treatments

Novel anticancer medicines, including targeted therapies and immune checkpoint inhibitors, have greatly improved the management of cancers. However, both conventional and new anticancer treatments induce cardiac adverse effects, which remain a critical issue in clinic. Cardiotoxicity induced by anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Audebrand, Anais, Désaubry, Laurent, Nebigil, Canan G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993588/
https://www.ncbi.nlm.nih.gov/pubmed/32039239
http://dx.doi.org/10.3389/fcvm.2019.00194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993588/
https://www.ncbi.nlm.nih.gov/pubmed/32039239
http://dx.doi.org/10.3389/fcvm.2019.00194

Ejemplares similares